Journal of Diabetes and Its Complications
Volume 17, Issue 4 , Pages 218-228 , July 2003

The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones

  • Andrew S. Greenberg

      Affiliations

    • Corresponding Author InformationJean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, 136 Harrison Avenue, Boston, MA 02111, USA. Tel.: +1-617-556-3144

Received 2 October 2002 ,Revised 20 December 2002 ,Accepted 30 December 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1056-8727(03)00002-3

doi: 10.1016/S1056-8727(03)00002-3

Journal of Diabetes and Its Complications
Volume 17, Issue 4 , Pages 218-228 , July 2003

Article Tools

* Image Usage & Resolution